Retrospective study focusing on efficacy and safety of Omidenepag isopropyl
Not Applicable
- Conditions
- Glaucoma or Ocular hypertension
- Registration Number
- JPRN-UMIN000040040
- Lead Sponsor
- Santen Pharmaceutical Co. Ltd.
- Brief Summary
Refer to paper
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 827
Inclusion Criteria
Not provided
Exclusion Criteria
There is no exclusion criteria in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IOP-lowering effect
- Secondary Outcome Measures
Name Time Method